Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

• Main Authors: Robert A Harrison (Author), George O Oluoch (Author), Stuart Ainsworth (Author), Jaffer Alsolaiss (Author), Fiona Bolton (Author), Ana-Silvia Arias (Author), José-María Gutiérrez (Author), Paul Rowley (Author), Stephen Kalya (Author), Hastings Ozwara (Author), Nicholas R Casewell (Author)
• Format: Bog
• Udgivet: Public Library of Science (PLoS), 2017-10-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

<h4>Background</h4>Antivenom is the treatment of choice for snakebite, which annually kills an estimated 32,000 people in sub-Saharan Africa and leaves approximately 100,000 survivors with permanent physical disabilities that exert a considerable socioeconomic burden. Over the past two d...